IPAR INTERPARFUMS INC
Perfumes, Cosmetics & Other Toilet Preparations · Nasdaq · SEC CIK 822663 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY2.6%
TTM net income YoY3.4%
TTM EPS YoY3.3%
Revenue 3-yr CAGR4.9%
Net income 3-yr CAGR2.3%
Margins
Gross margin64.8%
Operating margin17.9%
Net margin11.3%
FCF margin16.2%
EBITDA margin19.5%
Returns
ROE19.5%
ROA10.8%
ROIC (approx.)19.0%
Asset turnover0.96x
Leverage & solvency
Liabilities / assets30.1%
Debt / equity0.22x
Current ratio3.33x
Interest coverage44.33x
Cash quality & payout
Operating cash flow / net income1.46x
Accruals ratio-5.0%
Payout ratio60.2%
Capex / revenue0.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.49B | $1.45B | $1.32B | $1.09B | $879.50M |
| Cost of revenue | $541.29M | $524.98M | $478.60M | $392.23M | $322.61M |
| Gross profit | $947.22M | $927.34M | $839.08M | $694.42M | $556.90M |
| SG&A expense | $676.90M | $648.54M | $587.70M | $492.37M | $406.46M |
| Operating income | $270.32M | $274.80M | $251.38M | $194.30M | $148.05M |
| Interest expense | $7.25M | $7.83M | $11.25M | $3.60M | $2.83M |
| Pretax income | $271.33M | $268.39M | $249.59M | $194.22M | $151.02M |
| Income tax | $63.19M | $64.96M | $61.82M | $43.18M | $40.99M |
| Net income | $168.39M | $164.36M | $152.65M | $120.94M | $87.41M |
| EBITDA | $295.62M | $303.15M | $268.71M | $216.84M | $160.75M |
| EPS (basic) | 5.25 | 5.13 | 4.77 | 3.80 | 2.76 |
| EPS (diluted) | 5.24 | 5.12 | 4.75 | 3.78 | 2.75 |
| Dividends declared per share | 3.20 | 3.00 | 2.50 | 2.00 | 1.00 |
| Weighted avg. shares (diluted) | 32.14M | 32.12M | 32.14M | 31.99M | 31.84M |
| Banking | |||||
| Provision for credit losses | — | — | $5.45M | $4.98M | $7.30M |
| Balance sheet | |||||
| Cash & equivalents | — | — | — | $104.71M | $159.61B |
| Short-term investments | $137.09M | $109.31M | $94.30M | $150.83M | $160.01M |
| Receivables | $320.62M | $274.70M | $247.24M | $197.58M | $159.28M |
| Inventory | $351.38M | $371.92M | $371.86M | $289.98M | $198.91M |
| Current assets | $1.03B | $926.40M | $839.03M | $787.72M | $709.72M |
| PP&E, net | $184.89M | $153.77M | $169.22M | $166.72M | $149.35M |
| Intangibles | $325.19M | $282.48M | $296.36M | $290.85M | $214.05M |
| Total assets | $1.59B | $1.41B | $1.37B | $1.31B | $1.15B |
| Current liabilities | $344.00M | $332.43M | $324.75M | $344.57M | $244.91M |
| Short-term debt | $54.77M | $41.61M | $29.59M | $28.55M | $15.91M |
| Long-term debt | $121.25M | $115.73M | $127.90M | $151.49M | $132.90M |
| Total debt | $176.03M | $157.34M | $157.48M | $180.04M | $148.81M |
| Total liabilities | $481.22M | $468.62M | $477.16M | $520.40M | $407.03M |
| Shareholders' equity | $880.72M | $744.87M | $699.39M | $616.78M | $571.92M |
| Net debt | — | — | — | $75.33M | -$159.46B |
| Shares outstanding | 32.07M | 32.11M | 32.00M | 31.97M | 31.83M |
| Cash flow statement | |||||
| Operating cash flow | $214.90M | $187.64M | $105.77M | $73.03M | $119.59M |
| Capital expenditure | $24.41M | $4.74M | $6.46M | $33.76M | $141.27M |
| Free cash flow | $190.49M | $182.90M | $99.31M | $39.27M | -$21.69M |
| Investing cash flow | -$61.15M | -$44.83M | $7.26M | -$90.64M | -$187.87M |
| Financing cash flow | -$131.25M | -$100.77M | -$133.21M | -$45.57M | $78.19M |
| Depreciation & amortization | $25.30M | $28.36M | $17.33M | $22.54M | $12.70M |
| Stock-based compensation | $1.57M | $2.38M | $2.52M | $3.14M | $2.85M |
| Dividends paid | $102.72M | $96.03M | $80.05M | $63.74M | $31.69M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-19 06:28.